BIRC5 and leukemia: Specifically, we examined the effect of MUC1‐C silencing on the expression of survivin, a target gene of the WNT/β‐catenin/TCF pathway, which is critical for leukaemia survival, resistance to apoptosis and disease progression.14, 16, 17, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30